N

Nippon Chemiphar Co Ltd

12 employees

Nippon Chemiphar manufactures, sells, imports, and exports ethical pharmaceuticals and diagnostic agents for the healthcare business.

Investor insights

Sectors invested in

Artificial Intelligence3
Biomolecule2
Biopharma2
Biotechnology2
Pharmaceutical2
Drug Discovery2
peptide2
Directed Evolution2
Machine Learning2
Antibody2
NGS2
molecular biology2
Health Care1
Task Management1
Nursing and Residential Care1

Funding rounds participated in

$5M sweet spot round size

Most of their 3 investments are in rounds between $2.7M and $7.3M

Basic info

Sectors

Health Care
Pharmaceutical
Manufacturing

Date founded

1950

Investments made

M

MOLCURE Inc. raised $7.3M on August 18, 2021

Investors: SBI Investment, STRIVE, GMO VenturePartners,Inc. and Nippon Chemiphar Co Ltd

サスメド株式会社 raised undisclosed on August 24, 2020

Investors: Sumitomo Corporation and Nippon Chemiphar Co Ltd

M

MOLCURE Inc. raised $2.7M on December 25, 2018

Investors: GMO VenturePartners,Inc., The Dai-ichi Life Insurance Company, Limited and Nippon Chemiphar Co Ltd

FAQ